Sundrug Co(SDGCF)
$24.49+-0.34 (+4.99%)
SDGCF
Sundrug Co financials statements
$24.49
At close:+-0.34 (+4.99%)
Sundrug Co (SDGCF) Ratios
7 Followers
Sundrug Co Ratios
SDGCF's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, SDGCF's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.69 | 1.78 | 1.34 | 1.82 | 2.08 |
| Quick Ratio | 0.92 | 0.95 | 0.75 | 1.09 | 1.32 |
| Cash Ratio | 0.51 | 0.53 | 0.45 | 0.71 | 0.93 |
| Solvency Ratio | 0.27 | 0.26 | 0.27 | 0.30 | 0.32 |
| Operating Cash Flow Ratio | 0.32 | 0.32 | 0.26 | 0.33 | 0.33 |
| Short-Term Operating Cash Flow Coverage | 8.48 | 7.05 | 1.18 | 439.76 | 660.04 |
| Net Current Asset Value | ¥ 41.41B | ¥ 48.56B | ¥ 41.13B | ¥ 81.56B | ¥ 94.36B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.10 | 0.08 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.15 | 0.17 | 0.14 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.13 | 0.14 | 0.12 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.13 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.65 | 1.66 | 1.66 | 1.53 | 1.48 |
| Debt Service Coverage Ratio | 9.63 | 7.75 | 1.27 | 312.45 | 597.75 |
| Interest Coverage Ratio | 271.32 | 121.96 | 1281.16 | 1040.33 | 3783.56 |
| Debt to Market Cap | 0.08 | 0.11 | 0.06 | 0.00 | 0.00 |
| Interest Debt Per Share | 338.90 | 415.45 | 299.57 | 8.34 | 4.60 |
| Net Debt to EBITDA | -0.42 | -0.34 | -0.61 | -1.60 | -1.98 |
| Profitability Margins | |||||
| Gross Profit Margin | 23.30% | 23.43% | 25.18% | 24.90% | 24.12% |
| EBIT Margin | 5.45% | 5.48% | 5.49% | 5.47% | 5.35% |
| EBITDA Margin | 7.62% | 7.71% | 7.52% | 7.21% | 6.92% |
| Operating Profit Margin | 5.55% | 5.56% | 5.45% | 5.42% | 5.25% |
| Pretax Profit Margin | 5.43% | 5.44% | 5.49% | 5.46% | 5.35% |
| Net Profit Margin | 3.84% | 3.73% | 3.87% | 3.72% | 3.68% |
| Continuous Operations Profit Margin | 3.84% | 3.73% | 3.87% | 3.72% | 3.68% |
| Net Income Per EBT | 70.58% | 68.54% | 70.59% | 68.16% | 68.79% |
| EBT Per EBIT | 97.91% | 97.80% | 100.64% | 100.69% | 101.83% |
| Return on Assets (ROA) | 6.91% | 6.60% | 6.93% | 7.13% | 7.32% |
| Return on Equity (ROE) | 11.40% | 10.98% | 11.51% | 10.88% | 10.81% |
| Return on Capital Employed (ROCE) | 14.06% | 13.72% | 15.49% | 15.14% | 14.82% |
| Return on Invested Capital (ROIC) | 9.77% | 9.23% | 9.66% | 10.31% | 10.20% |
| Return on Tangible Assets | 7.05% | 6.72% | 7.09% | 7.31% | 7.46% |
| Earnings Yield | 6.25% | 6.86% | 5.35% | 6.05% | 6.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 16.57 | 16.36 | 17.63 | 18.41 | 19.39 |
| Payables Turnover | 7.71 | 7.80 | 7.27 | 6.70 | 6.65 |
| Inventory Turnover | 6.23 | 5.85 | 6.16 | 6.25 | 6.79 |
| Fixed Asset Turnover | 5.87 | 5.67 | 6.24 | 5.43 | 8.33 |
| Asset Turnover | 1.80 | 1.77 | 1.79 | 1.91 | 1.99 |
| Working Capital Turnover Ratio | 11.37 | 8.76 | 10.34 | 7.04 | 6.40 |
| Cash Conversion Cycle | 33.27 | 37.93 | 29.74 | 23.81 | 17.74 |
| Days of Sales Outstanding | 22.03 | 22.31 | 20.70 | 19.83 | 18.83 |
| Days of Inventory Outstanding | 58.56 | 62.42 | 59.24 | 58.45 | 53.79 |
| Days of Payables Outstanding | 47.32 | 46.80 | 50.21 | 54.46 | 54.88 |
| Operating Cycle | 80.59 | 84.73 | 79.95 | 78.27 | 72.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 351.94 | 370.13 | 352.21 | 319.70 | 270.98 |
| Free Cash Flow Per Share | 65.94 | 110.80 | 25.34 | 96.36 | 101.72 |
| Dividend Paid and CapEx Coverage Ratio | 0.86 | 0.95 | 0.81 | 1.03 | 1.13 |
| Capital Expenditure Coverage Ratio | 1.23 | 1.43 | 1.08 | 1.43 | 1.60 |
| Operating Cash Flow Coverage Ratio | 1.04 | 0.90 | 1.18 | 39.81 | 59.89 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Free Cash Flow Yield | 1.57% | 2.83% | 0.54% | 2.65% | 3.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.01 | 14.57 | 18.69 | 16.54 | 14.58 |
| Price-to-Sales (P/S) Ratio | 0.61 | 0.54 | 0.72 | 0.62 | 0.54 |
| Price-to-Book (P/B) Ratio | 1.83 | 1.60 | 2.15 | 1.80 | 1.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 63.83 | 35.29 | 183.72 | 37.72 | 29.25 |
| Price-to-Operating Cash Flow Ratio | 11.96 | 10.56 | 13.22 | 11.37 | 10.98 |
| Price-to-Earnings Growth (PEG) Ratio | 2.88 | 7.02 | 1.41 | 2.13 | -2.50 |
| Enterprise Value Multiple | 7.64 | 6.70 | 9.02 | 6.93 | 5.77 |
| Enterprise Value | 466.81B | 435.08B | 509.67B | 345.08B | 259.03B |
| EV to EBITDA | 7.64 | 6.70 | 9.02 | 6.93 | 5.77 |
| EV to Sales | 0.58 | 0.52 | 0.68 | 0.50 | 0.40 |
| EV to Free Cash Flow | 60.52 | 33.57 | 172.01 | 30.63 | 21.78 |
| EV to Operating Cash Flow | 11.34 | 10.05 | 12.37 | 9.23 | 8.18 |
| Tangible Book Value Per Share | 2231.89 | 2375.68 | 2086.04 | 1943.35 | 1835.81 |
| Shareholders’ Equity Per Share | 2305.97 | 2444.91 | 2164.22 | 2021.21 | 1886.73 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | 0.31 | 0.29 | 0.32 | 0.31 |
| Revenue Per Share | 6855.27 | 7202.31 | 6428.59 | 5905.26 | 5548.64 |
| Net Income Per Share | 262.90 | 268.36 | 249.06 | 219.83 | 204.02 |
| Tax Burden | 0.71 | 0.69 | 0.71 | 0.68 | 0.69 |
| Interest Burden | 1.00 | 0.99 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.18 | 0.18 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.34 | 1.38 | 1.41 | 0.99 | 0.91 |
Currency in JPY
